The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.715
Bid: 0.65
Ask: 0.70
Change: 0.09 (14.40%)
Spread: 0.05 (7.692%)
Open: 0.625
High: 0.715
Low: 0.715
Prev. Close: 0.625
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM, board change and change of name

7 Jul 2011 07:00

RNS Number : 9061J
Ultima Networks PLC
07 July 2011
 



Embargoed for 07:00 7 July 2011

 

Ultima Networks plc

("Ultima" or the "Company")

 

Result of annual general meeting ("AGM"), board change and change of name

 

The board of directors of Ultima (the "Board") announces that at the AGM held yesterday all resolutions were duly passed, except for Resolution 3. This resolution related to the appointment of Matteo Turi as a director of the Company and was not passed as, since it was proposed, he has accepted a role that potentially conflicts with his duties at Ultima and is stepping down from the Board with immediate effect.

 

One of the resolutions passed was the proposed change of name of the Company from Ultima Networks plc to Ultima plc in order to align more closely the Company's name with its existing business activities. Following shareholder approval the Board will now submit the required application to Companies House to record the change of name. The change of name will only become effective once Companies House has issued a certificate of incorporation on change of name. The Company will continue to be traded under the ticker UTN.

 

Further announcements will be made in due course regarding the change of name.

 

Professor Humayun Mughal commented: "We are sad to see Matteo leave Ultima after only a short period of time with the Company. We would like to thank Matteo for his contribution to the Company and we wish him all the best for the future."

 

For further information, please contact:

 

Ultima

Tel: 01279 821 200

Prof. Humayun Mughal, Chairman and CEO

David Nuttall, Company Secretary

 

Allenby Capital Limited (Nominated Adviser and Broker)

Tel: 020 3328 5656

Nick Naylor

Nick Athanas

Dan Robinson

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGZQLFBFDFLBBQ
Date   Source Headline
16th Mar 202010:26 amRNSHolding(s) in Company
4th Mar 20207:00 amRNSPosting of Annual Report and Notice of AGM
25th Feb 20207:00 amRNSFinal Results
11th Feb 20207:00 amRNSResearch Collaboration Agreement
29th Jan 20207:00 amRNSUpdate on Nuvec® process improvements
18th Sep 20197:00 amRNSInterim Results
20th Aug 20197:00 amRNSResults of University of Queensland Study
13th Aug 201911:16 amRNSHolding(s) in Company
15th Jul 20192:05 pmRNSSecond Price Monitoring Extn
15th Jul 20192:00 pmRNSPrice Monitoring Extension
3rd Jul 20194:40 pmRNSSecond Price Monitoring Extn
3rd Jul 20194:35 pmRNSPrice Monitoring Extension
19th Jun 201912:51 pmRNSResult of AGM
19th Jun 20197:00 amRNSAGM Statement
14th Jun 20194:41 pmRNSSecond Price Monitoring Extn
14th Jun 20194:36 pmRNSPrice Monitoring Extension
28th May 20192:21 pmRNSChange to Director Shareholding
22nd May 20197:00 amRNSPosting of Annual Report and Notice of AGM
21st May 20197:00 amRNSBoard Changes
14th May 20197:00 amRNSFinal Results
15th Apr 20197:00 amRNSNuvec® Research update
10th Apr 201911:52 amRNSDirector/PDMR Shareholding
9th Apr 20197:00 amRNSNuvec® Research update
20th Mar 20199:40 amRNSHolding(s) in Company
20th Mar 20199:40 amRNSHolding(s) in Company
28th Feb 20195:00 pmRNSTotal Voting Rights
14th Feb 20192:14 pmRNSHolding(s) in Company
8th Feb 201912:23 pmRNSPlacing to raise £1.05 million
20th Dec 20187:00 amRNSNuvec licence extension
28th Nov 20187:00 amRNSNuvec® research update
16th Nov 20181:36 pmRNSNuvec resource changes
15th Nov 20187:00 amRNSFiling of further Nuvec® patent application
14th Nov 201811:05 amRNSSecond Price Monitoring Extn
14th Nov 201811:00 amRNSPrice Monitoring Extension
14th Nov 20189:05 amRNSSecond Price Monitoring Extn
14th Nov 20189:00 amRNSPrice Monitoring Extension
8th Nov 20184:40 pmRNSSecond Price Monitoring Extn
8th Nov 20184:35 pmRNSPrice Monitoring Extension
8th Nov 20182:05 pmRNSSecond Price Monitoring Extn
8th Nov 20182:00 pmRNSPrice Monitoring Extension
5th Nov 201811:06 amRNSSecond Price Monitoring Extn
5th Nov 201811:00 amRNSPrice Monitoring Extension
5th Nov 20189:00 amRNSPrice Monitoring Extension
5th Nov 20187:54 amRNSResearch collaboration update
29th Oct 20187:00 amRNSNuvec® research update
2nd Oct 201811:44 amRNSResearch collaboration for novel DNA vaccine
26th Sep 20181:48 pmRNSGrant of options
26th Sep 201811:00 amRNSPrice Monitoring Extension
24th Sep 20184:41 pmRNSSecond Price Monitoring Extn
24th Sep 20184:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.